Powered by

EpicGenetics Announces 50 Percent Increase in Fibromyalgia FM/a® Test Requests Since September

Nov 20, 2018 - Business Wire

EpicGenetics , the biomedical company that developed and offers the FM/a Test, the FDA-compliant diagnostic blood test that identifies the immune system biomarkers of fibromyalgia, today announced a 50 percent growth in applications for the test.

In September, the U.S. Food and Drug Administration (FDA) approved the Massachusetts General Hospital for a human clinical trial of BCG (an inexpensive generic vaccine used globally to prevent tuberculosis) to treat and reverse the biology of fibr...